DNA Methylation Market Size, Share & Trends Analysis Report By Product & Service (Reagents & Kits, Instruments), By Technique, By Application (Oncology, Stem Cell Research), By End-use (Academic & Research Institutes, Hospitals & Clinical Laboratories), B
Description
DNA Methylation Market Summary
The global DNA methylation market size was estimated at USD 1.64 billion in 2024 and is projected to reach USD 5.52 billion by 2033, growing at a CAGR of 14.73% from 2025 to 2033. The rising prevalence of cancer and other chronic diseases primarily drives market growth.
For instance, according to the National Cancer Institute, in 2025, approximately 2.04 million new cancer cases are expected to be diagnosed in the U.S., with an estimated 618,120 deaths projected to result from the disease.
Global DNA Methylation Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the global DNA methylation market on the basis of product & services, technique, application, end-use, and region:
The global DNA methylation market size was estimated at USD 1.64 billion in 2024 and is projected to reach USD 5.52 billion by 2033, growing at a CAGR of 14.73% from 2025 to 2033. The rising prevalence of cancer and other chronic diseases primarily drives market growth.
For instance, according to the National Cancer Institute, in 2025, approximately 2.04 million new cancer cases are expected to be diagnosed in the U.S., with an estimated 618,120 deaths projected to result from the disease.
Global DNA Methylation Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the global DNA methylation market on the basis of product & services, technique, application, end-use, and region:
- Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
- Kits & Reagents
- Instruments
- Services
- Technique Outlook (Revenue, USD Million, 2021 - 2033)
- PCR-Based Techniques
- Sequencing-Based Techniques
- Microarray-Based Techniques
- Others
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Oncolgy
- Neurological Disorders
- Stem Cell Research
- Others
- End-use Outlook (Revenue, USD Million, 2021 - 2033)
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Hospitals & Clinical Laboratories
- Others
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
120 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.2.1. Product & Service
- 1.2.2. Technique
- 1.2.3. Application
- 1.2.4. End Use
- 1.3. Information analysis
- 1.4. Market formulation & data visualization
- 1.5. Data validation & publishing
- 1.6. Information Procurement
- 1.6.1. Primary Research
- 1.7. Information or Data Analysis
- 1.8. Market Formulation & Validation
- 1.9. Market Model
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
- Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Ancillary Market Outlook
- 3.2. Market Trends and Outlook
- 3.3. Market Dynamics
- 3.3.1. Market Driver Impact Analysis
- 3.3.1.1. Advancements in epigenetic research
- 3.3.1.2. Advancements in sequencing and analytical technologies
- 3.3.2. Market Restraint Impact Analysis
- 3.3.2.1. High cost and technical complexity
- 3.3.2.2. Uncertainty in regulatory frameworks
- 3.4. Business Environment Analysis
- 3.4.1. PESTLE Analysis
- 3.4.2. PORTER’S Five Forces Analysis
- Chapter 4. Product & Service Business Analysis
- 4.1. Product Segment Dashboard
- 4.2. Global DNA Methylation Market Product & Service, Movement Analysis
- 4.3. Global DNA Methylation Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
- 4.4. Kits & Reagents
- 4.4.1. Global kits & reagents market estimates and forecasts, 2021 - 2033 (USD million)
- 4.5. Instruments
- 4.5.1. Global instruments market estimates and forecasts, 2021 - 2033 (USD million)
- 4.6. Services
- 4.6.1. Global services market estimates and forecasts, 2021 - 2033 (USD million)
- Chapter 5. Technique Business Analysis
- 5.1. Technique Segment Dashboard
- 5.2. Global DNA Methylation Market Technique, Movement Analysis
- 5.3. Global DNA Methylation Market Size & Trend Analysis, by Technique, 2021 to 2033 (USD Million)
- 5.4. PCR-Based Techniques
- 5.4.1. Global PCR-Based techniques market estimates and forecasts, 2021 - 2033 (USD million)
- 5.5. Microarray-Based Techniques
- 5.5.1. Global microarray-based techniques market estimates and forecasts, 2021 - 2033 (USD million)
- 5.6. Sequencing -based techniques
- 5.6.1. Global sequencing-based techniques market estimates and forecasts, 2021 - 2033 (USD million)
- 5.7. Others
- 5.7.1. Global others market estimates and forecasts, 2021 - 2033 (USD million)
- Chapter 6. Application Business Analysis
- 6.1. Application Segment Dashboard
- 6.2. Global DNA Methylation Market Application, Movement Analysis
- 6.3. Global DNA Methylation Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
- 6.4. Oncology
- 6.4.1. Global oncology market estimates and forecasts, 2021 - 2033 (USD million)
- 6.5. Neurological Disorders
- 6.5.1. Global neurological disorders market estimates and forecasts, 2021 - 2033 (USD million)
- 6.6. Stem Cell Research
- 6.6.1. Global stem cell research market estimates and forecasts, 2021 - 2033 (USD million)
- 6.7. Others
- 6.7.1. Global others market estimates and forecasts, 2021 - 2033 (USD million)
- Chapter 7. End Use Business Analysis
- 7.1. End Use Segment Dashboard
- 7.2. Global DNA Methylation Market End Use, Movement Analysis
- 7.3. Global DNA Methylation Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
- 7.4. Hospital & Clinical Laboratories
- 7.4.1. Global hospital & clinical laboratories market estimates and forecasts, 2021 - 2033 (USD million)
- 7.5. Pharmaceutical & Biotechnology Companies
- 7.5.1. Global pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD million)
- 7.6. Academic & Research Institutes
- 7.6.1. Global academic & research institutions market estimates and forecasts, 2021 - 2033 (USD million)
- 7.7. Others
- 7.7.1. Global others market estimates and forecasts, 2021 - 2033 (USD million)
- Chapter 8. DNA Methylation Market: Regional Estimates and Trend Analysis, by Product, Technique, Application, & End Use
- 8.1. Regional Dashboard
- 8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
- 8.3. North America
- 8.3.1. North America DNA methylation market, 2021 - 2033 (USD Million)
- 8.3.2. U.S.
- 8.3.2.1. Key Country Dynamics
- 8.3.2.2. Competitive Scenario
- 8.3.2.3. Regulatory Framework
- 8.3.2.4. U.S. DNA methylation market, 2021 - 2033 (USD Million)
- 8.3.3. Canada
- 8.3.3.1. Key Country Dynamics
- 8.3.3.2. Competitive Scenario
- 8.3.3.3. Regulatory Framework
- 8.3.3.4. Canada DNA methylation market, 2021 - 2033 (USD Million)
- 8.3.4. Mexico
- 8.3.4.1. Key Country Dynamics
- 8.3.4.2. Competitive Scenario
- 8.3.4.3. Regulatory Framework
- 8.3.4.4. Mexcio DNA methylation market, 2021 - 2033 (USD Million)
- 8.4. Europe
- 8.4.1. Europe DNA methylation market, 2021 - 2033 (USD Million)
- 8.4.2. UK
- 8.4.2.1. Key Country Dynamics
- 8.4.2.2. Competitive Scenario
- 8.4.2.3. Regulatory Framework
- 8.4.2.4. UK DNA methylation market, 2021 - 2033 (USD Million)
- 8.4.3. Germany
- 8.4.3.1. Key Country Dynamics
- 8.4.3.2. Competitive Scenario
- 8.4.3.3. Regulatory Framework
- 8.4.3.4. Germany DNA methylation market, 2021 - 2033 (USD Million)
- 8.4.4. France
- 8.4.4.1. Key Country Dynamics
- 8.4.4.2. Competitive Scenario
- 8.4.4.3. Regulatory Framework
- 8.4.4.4. France DNA methylation market, 2021 - 2033 (USD Million)
- 8.4.5. Italy
- 8.4.5.1. Key Country Dynamics
- 8.4.5.2. Competitive Scenario
- 8.4.5.3. Regulatory Framework
- 8.4.5.4. Italy DNA methylation market, 2021 - 2033 (USD Million)
- 8.4.6. Spain
- 8.4.6.1. Key Country Dynamics
- 8.4.6.2. Competitive Scenario
- 8.4.6.3. Regulatory Framework
- 8.4.6.4. Spain DNA methylation market, 2021 - 2033 (USD Million)
- 8.4.7. Denmark
- 8.4.7.1. Key Country Dynamics
- 8.4.7.2. Competitive Scenario
- 8.4.7.3. Regulatory Framework
- 8.4.7.4. Denmark DNA methylation market, 2021 - 2033 (USD Million)
- 8.4.8. Sweden
- 8.4.8.1. Key Country Dynamics
- 8.4.8.2. Competitive Scenario
- 8.4.8.3. Regulatory Framework
- 8.4.8.4. Sweden DNA methylation market, 2021 - 2033 (USD Million)
- 8.4.9. Norway
- 8.4.9.1. Key Country Dynamics
- 8.4.9.2. Competitive Scenario
- 8.4.9.3. Regulatory Framework
- 8.4.9.4. Norway DNA methylation market, 2021 - 2033 (USD Million)
- 8.5. Asia Pacific
- 8.5.1. Asia Pacific DNA methylation market, 2021 - 2033 (USD Million)
- 8.5.2. Japan
- 8.5.2.1. Key Country Dynamics
- 8.5.2.2. Competitive Scenario
- 8.5.2.3. Regulatory Framework
- 8.5.2.4. Japan DNA methylation market, 2021 - 2033 (USD Million)
- 8.5.3. China
- 8.5.3.1. Key Country Dynamics
- 8.5.3.2. Competitive Scenario
- 8.5.3.3. Regulatory Framework
- 8.5.3.4. China DNA methylation market, 2021 - 2033 (USD Million)
- 8.5.4. India
- 8.5.4.1. Key Country Dynamics
- 8.5.4.2. Competitive Scenario
- 8.5.4.3. Regulatory Framework
- 8.5.4.4. India DNA methylation market, 2021 - 2033 (USD Million)
- 8.5.5. Australia
- 8.5.5.1. Key Country Dynamics
- 8.5.5.2. Competitive Scenario
- 8.5.5.3. Regulatory Framework
- 8.5.5.4. Australia DNA methylation market, 2021 - 2033 (USD Million)
- 8.5.6. Thailand
- 8.5.6.1. Key Country Dynamics
- 8.5.6.2. Competitive Scenario
- 8.5.6.3. Regulatory Framework
- 8.5.6.4. Thailand DNA methylation market, 2021 - 2033 (USD Million)
- 8.5.7. South Korea
- 8.5.7.1. Key Country Dynamics
- 8.5.7.2. Competitive Scenario
- 8.5.7.3. Regulatory Framework
- 8.5.7.4. South Korea DNA methylation market, 2021 - 2033 (USD Million)
- 8.6. Latin America
- 8.6.1. Latin America DNA methylation market, 2021 - 2033 (USD Million)
- 8.6.2. Brazil
- 8.6.2.1. Key Country Dynamics
- 8.6.2.2. Competitive Scenario
- 8.6.2.3. Regulatory Framework
- 8.6.2.4. Brazil DNA methylation market, 2021 - 2033 (USD Million)
- 8.6.3. Argentina
- 8.6.3.1. Key Country Dynamics
- 8.6.3.2. Competitive Scenario
- 8.6.3.3. Regulatory Framework
- 8.6.3.4. Argentina DNA methylation market, 2021 - 2033 (USD Million)
- 8.7. MEA
- 8.7.1. MEA DNA methylation market, 2021 - 2033 (USD Million)
- 8.7.2. South Africa
- 8.7.2.1. Key Country Dynamics
- 8.7.2.2. Competitive Scenario
- 8.7.2.3. Regulatory Framework
- 8.7.2.4. South Africa DNA methylation market, 2021 - 2033 (USD Million)
- 8.7.3. Saudi Arabia
- 8.7.3.1. Key Country Dynamics
- 8.7.3.2. Competitive Scenario
- 8.7.3.3. Regulatory Framework
- 8.7.3.4. Saudi Arabia DNA methylation market, 2021 - 2033 (USD Million)
- 8.7.4. UAE
- 8.7.4.1. Key Country Dynamics
- 8.7.4.2. Competitive Scenario
- 8.7.4.3. Regulatory Framework
- 8.7.4.4. UAE DNA methylation market, 2021 - 2033 (USD Million)
- 8.7.5. Kuwait
- 8.7.5.1. Key Country Dynamics
- 8.7.5.2. Competitive Scenario
- 8.7.5.3. Regulatory Framework
- 8.7.5.4. Kuwait DNA methylation market, 2021 - 2033 (USD Million)
- Chapter 9. Competitive Landscape
- 9.1. Company Categorization
- 9.2. Strategy Mapping
- 9.3. Company Market Position Analysis, 2024
- 9.4. Company Profiles/Listing
- 9.4.1. New England Biolabs
- 9.4.1.1. Overview
- 9.4.1.2. Financial Performance
- 9.4.1.3. Product Benchmarking
- 9.4.1.4. Strategic Initiatives
- 9.4.2. Abcam Limited
- 9.4.2.1. Overview
- 9.4.2.2. Financial Performance
- 9.4.2.3. Product Benchmarking
- 9.4.2.4. Strategic Initiatives
- 9.4.3. F. Hoffmann-La Roche Ltd
- 9.4.3.1. Overview
- 9.4.3.2. Financial Performance
- 9.4.3.3. Product Benchmarking
- 9.4.3.4. Strategic Initiatives
- 9.4.4. Diagenode Diagnostics S.A.
- 9.4.4.1. Overview
- 9.4.4.2. Financial Performance
- 9.4.4.3. Product Benchmarking
- 9.4.4.4. Strategic Initiatives
- 9.4.5. Thermo-Fisher Scientific Inc.
- 9.4.5.1. Overview
- 9.4.5.2. Financial Performance
- 9.4.5.3. Product Benchmarking
- 9.4.5.4. Strategic Initiatives
- 9.4.6. Agilent Technologies Inc.
- 9.4.6.1. Overview
- 9.4.6.2. Financial Performance
- 9.4.6.3. Product Benchmarking
- 9.4.6.4. Strategic Initiatives
- 9.4.7. Bio-Rad Laboratories, Inc.
- 9.4.7.1. Overview
- 9.4.7.2. Financial Performance
- 9.4.7.3. Product Benchmarking
- 9.4.7.4. Strategic Initiatives
- 9.4.8. QIAGEN
- 9.4.8.1. Overview
- 9.4.8.2. Financial Performance
- 9.4.8.3. Product Benchmarking
- 9.4.8.4. Strategic Initiatives
- 9.4.9. Active Motif, Inc.
- 9.4.9.1. Overview
- 9.4.9.2. Financial Performance
- 9.4.9.3. Product Benchmarking
- 9.4.9.4. Strategic Initiatives
- 9.4.10. Illumina Inc.
- 9.4.10.1. Overview
- 9.4.10.2. Financial Performance
- 9.4.10.3. Product Benchmarking
- 9.4.10.4. Strategic Initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


